Prominent Players - Ulcerative Colitis Industry

The high prevalence of ulcerative colitis in developed nations and the rising incidence rate in emerging economies will be key factors driving market growth. Industrialised nations have the greatest incidence rate of ulcerative colitis, according to a CCFA study. Although it can affect persons of any age, the disease is more common in urban than rural regions, with most cases being diagnosed in patients between the ages of 15 and 35. According to statistics from the World Gastroenterology Organisation (WGO), the incidence rate is rising in developing nations like India. The incidence of ulcerative colitis would likely increase rapidly in the emerging nations in the near future as a result of dietary and lifestyle changes. Europe has the greatest yearly rate of incidence in the globe, followed by North America, while Asia and the Middle East have the lowest, according to data gathered from numerous sources and compiled by Coherent Market Insights.

Coherent Market Insights estimates that the market for Ulcerative Colitis was estimated to be worth $6.2 billion in 2020, and it is anticipated to increase to $10.8 billion by 2030, with a CAGR of 5.7% between 2021 and 2030.

Top Companies in the Ulcerative Colitis Industry:

1. F. Hoffmann-La Roche AG

The business is headquartered in Basel, Switzerland, and was founded in 1896. F. Hoffmann-La Roche AG provides cancer and transplant drugs in addition to in-vitro diagnostics. In March 2021, Roche declared that it would buy GenMark Diagnostics for $1.8 billion. To grow its molecular diagnostics business, the organisation declared in September 2021 that it will buy the German biotech firm TIB Molbiol.

2. Johnson & Johnson

The corporate headquarters of Johnson & Johnson, a company that was founded in 1886, are located in New Brunswick, New Jersey. Manufacturers of consumer goods, prescription medications, and medical equipment include Johnson & Johnson. The company announced in November 2021 that it would split into two publicly traded companies, one focusing on consumer items and the other on pharmaceuticals and medical technologies. The company claimed that during the first quarter of April 2021, sales of their Covid-19 vaccine totaled $100 million. In November 2022, Johnson & Johnson acquired Abiomed Inc. for $16.6 billion.

3. Takeda Pharmaceutical Company Limited

The pharmaceutical business Takeda was established in 1781, and on January 29, 1925, it became a corporation. The company's main research interests include oncology, rare diseases, neurology, gastrointestinal, particle medicine, and vaccinations. The TYK2 Programme Subsidiary of Nimbus Therapeutics was completely acquired by Takeda in February 2023. In October 2022, Takeda and Zedira and Dr. Falk Pharma signed a cooperation and licencing agreement to work together to create a first-in-class medication for celiac disease.

4. AbbVie Inc.

The company was founded in 2012 and is based in Illinois, United States. Pharmaceutical product development and research are done by AbbVie Inc. With its main product SDI-118 and portfolio of cutting-edge modulators of the synaptic vesicle protein 2A, Syndesi Therapeutics was purchased by Abbvie in March 2022 for up to $1 billion. TeneoOne and its lead chemical TNB-383B were purchased by Abbvie in June 2021.

5. Hospira

The firm was founded in 2004 and is located in Illinois, United States. The company Hospira, Inc. produces and retails generic pharmaceuticals. Hospira, Inc. was a brand name used by Pfizer in 2020 to indicate to the subsidiary's role as a supplier of 0.9% Sodium chloride Injection USP diluent for the Pfizer-BioNTech COVID-19 vaccine.

6. Janssen Pharmaceuticals Inc.

The firm was founded in 1953 and is based in Beerse, Belgium. The business offers pharmaceutical goods. The company sells prescription drugs for general medicine, women's health, pain management, neurologics, and mental health.

7. Celltrion Healthcare

The business was started in 1999 and is based in South Korea. Pharmaceutical biologics and chemically synthesised medications are developed and produced by the company. The Company specialises in the creation of medications for the treatment of breast cancer, rheumatoid arthritis, leukaemia, psoriasis, human rabies, and influenza.

*Definition:

The most prevalent kind of inflammatory bowel disease that affects the colon (line of the large intestine) and rectum is ulcerative colitis. Ulcers are microscopic lesions that are caused by inflammation.